CN1968705A - 碳硼烷基卟啉及其应用 - Google Patents

碳硼烷基卟啉及其应用 Download PDF

Info

Publication number
CN1968705A
CN1968705A CNA2005800203414A CN200580020341A CN1968705A CN 1968705 A CN1968705 A CN 1968705A CN A2005800203414 A CNA2005800203414 A CN A2005800203414A CN 200580020341 A CN200580020341 A CN 200580020341A CN 1968705 A CN1968705 A CN 1968705A
Authority
CN
China
Prior art keywords
carborane
main body
chemical compound
porphyrin
boron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800203414A
Other languages
English (en)
Chinese (zh)
Inventor
吴海涛
米希科·缪拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brookhaven Science Associates LLC
Original Assignee
Brookhaven Science Associates LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Associates LLC filed Critical Brookhaven Science Associates LLC
Publication of CN1968705A publication Critical patent/CN1968705A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
CNA2005800203414A 2004-05-20 2005-05-17 碳硼烷基卟啉及其应用 Pending CN1968705A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/848,741 US6995260B2 (en) 2004-05-20 2004-05-20 Carboranylporphyrins and uses thereof
US10/848,741 2004-05-20

Publications (1)

Publication Number Publication Date
CN1968705A true CN1968705A (zh) 2007-05-23

Family

ID=35375345

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800203414A Pending CN1968705A (zh) 2004-05-20 2005-05-17 碳硼烷基卟啉及其应用

Country Status (11)

Country Link
US (1) US6995260B2 (enExample)
EP (1) EP1753468A4 (enExample)
JP (1) JP2008505983A (enExample)
KR (1) KR20070026552A (enExample)
CN (1) CN1968705A (enExample)
AU (1) AU2005327597B2 (enExample)
CA (1) CA2567468A1 (enExample)
IL (1) IL179497A0 (enExample)
NO (1) NO20065858L (enExample)
NZ (1) NZ551732A (enExample)
WO (1) WO2006088476A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102268003A (zh) * 2011-06-16 2011-12-07 扬州大学 不对称多取代卟啉金(iii)类抗癌化合物及其制备方法
CN102725298A (zh) * 2009-10-28 2012-10-10 香港大学 作为组蛋白脱乙酰酶抑制剂的羟基取代的金(iii)卟啉络合物
CN114015066A (zh) * 2021-11-12 2022-02-08 北京大学 共价有机框架材料、其制备方法和用途

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
US20070093463A1 (en) * 2004-05-20 2007-04-26 Brookhaven Science Associates, Llc Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB0427589D0 (en) 2004-12-16 2005-01-19 Psimei Pharmaceuticals Plc Process for the preparation of a substituted porphyrin
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
WO2008102669A1 (ja) * 2007-02-19 2008-08-28 Rei Medical Co., Ltd. 新規な糖連結クロリン誘導体及びその製造方法
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
JP5745415B2 (ja) * 2009-09-17 2015-07-08 国立大学法人九州大学 ポルフィリン化合物
GB201221125D0 (en) * 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
KR102885276B1 (ko) * 2021-07-13 2025-11-11 삼성에스디아이 주식회사 염료, 이를 포함하는 조성물, 필름, 광학 부재 및 디스플레이 장치

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783529A (en) * 1985-12-03 1988-11-08 Research Corporation Technologies Rapid synthesis of radiolabeled porphyrin complexes for medical application
US5162231A (en) * 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
US4959356A (en) * 1989-05-26 1990-09-25 The United States Of America As Represented By The United States Department Of Energy Porphyrins for boron neutron capture therapy
FR2656866B1 (fr) * 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5654423A (en) * 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5312896A (en) * 1992-10-09 1994-05-17 Sri International Metal ion porphyrin-containing poly(imide)
DE4305523A1 (de) * 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
US5955586A (en) * 1996-03-22 1999-09-21 Sessler; Jonathan L. Highly boronated derivatives of texaphyrins
WO1998030102A1 (en) * 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
US6010805A (en) * 1998-05-26 2000-01-04 United States Of America As Represented By The Secretary Of The Air Force Ion conducting electrolyte material containing a lithium porphyrin complex
AU2001274827A1 (en) 2000-05-09 2001-11-20 The Regents Of The University Of California Porphyrin-based neutron capture agents for cancer therapy
US6566517B2 (en) * 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
US7087214B2 (en) * 2002-02-01 2006-08-08 Zentaris Gmbh Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
GB0222945D0 (en) * 2002-10-03 2002-11-13 Psimei Pharmaceuticals Plc Therapeutic compositions

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102725298A (zh) * 2009-10-28 2012-10-10 香港大学 作为组蛋白脱乙酰酶抑制剂的羟基取代的金(iii)卟啉络合物
CN102268003A (zh) * 2011-06-16 2011-12-07 扬州大学 不对称多取代卟啉金(iii)类抗癌化合物及其制备方法
CN114015066A (zh) * 2021-11-12 2022-02-08 北京大学 共价有机框架材料、其制备方法和用途
CN114015066B (zh) * 2021-11-12 2022-08-12 北京大学 共价有机框架材料、其制备方法和用途

Also Published As

Publication number Publication date
EP1753468A2 (en) 2007-02-21
WO2006088476A3 (en) 2006-12-21
JP2008505983A (ja) 2008-02-28
NZ551732A (en) 2011-03-31
EP1753468A4 (en) 2010-05-26
US6995260B2 (en) 2006-02-07
NO20065858L (no) 2007-02-09
KR20070026552A (ko) 2007-03-08
AU2005327597A1 (en) 2006-08-24
US20050260128A1 (en) 2005-11-24
AU2005327597B2 (en) 2011-02-24
WO2006088476A2 (en) 2006-08-24
IL179497A0 (en) 2011-08-01
CA2567468A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
JP5340953B2 (ja) カルボラニルポルフィリンとその使用
CN1968705A (zh) 碳硼烷基卟啉及其应用
CN1161697A (zh) β,β'-二羟基中位取代的二氢卟酚、异细菌二氢卟酚、细菌二氢卟酚,和从β,β'-未取代的四吡咯大环制备所述化合物的方法
US10456375B2 (en) Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
CN1988848B (zh) 碳硼烷基卟啉及其应用
HK1107013A (en) Carboranylporphyrins and uses thereof
HK1109039B (en) Carboranylporphyrins and uses thereof
Wu et al. Carboranylporphyrins and uses thereof
US20250115626A1 (en) Bifunctional linker comprising metaallylsilane and method for preparing same
Gottumukkala Syntheses and biological evaluation of water-soluble carboranylporphyrins for application in boron neutron capture therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1107013

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20070523

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1107013

Country of ref document: HK